Neuropathix
In completing his Ph.D. in natural products chemistry with David Kingston at Virginia Tech in December 2005, he isolated and characterized antitumor compounds from plant and marine sources. Following that, Jason Clement joined the Molecular Targets Laboratory at NCI-Frederick as a postdoctoral research fellow in January 2006. At NCI, he isolated compounds from plant and marine sources with activities in mechanism-based bioassays relevant to cancer.
This person is not in the org chart
This person is not in any offices
Neuropathix
Neuropathix is a biopharmaceutical company focused on the research and development of a pipeline pain management therapeutics.